Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Non-invasive Improvement of Buttocks With Magnetic Device

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03575507
Recruitment Status : Active, not recruiting
First Posted : July 2, 2018
Last Update Posted : July 4, 2018
Sponsor:
Information provided by (Responsible Party):
BTL Industries Ltd.

Brief Summary:

This study will evaluate the clinical safety and patient satisfaction with the high power magnet system for the aesthetic improvement of buttocks. The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete four (4) treatment visits and three follow-up visits - 1 month, 3 months and 12 months after the final treatment. Study will be conducted at several study sites.

At the baseline visit, subject's weight will be recorded.

The treatment administration phase will consist of four (4) treatments, delivered twice a week. The applicator will be applied over the gluteal area. Visible contractions will be induced by the device.

At the last therapy visit, the subject's weight will be recorded. In addition, subjects will receive Subject Satisfaction Questionnaire to fill in.

Safety measures will include documentation of adverse events (AE) including subject's experience of pain or discomfort after the procedure. Following each treatment administration and at the follow-up visits, subjects will be checked for immediate post-procedure adverse event assessment.

Post-procedure evaluation (follow-up visits) will be conducted 1 month, 3 months and 12 months after the final treatment. A weight measure will be conducted. Also, subject's satisfaction will be noted.


Condition or disease Intervention/treatment Phase
Muscle Tightness Device: Treatment with BTL EMSCULPT device. Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 21 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Safety and Patient Satisfaction With Noninvasive Repetitive Pulse Magnetic Stimulation (rPMS) for Aesthetic Improvements of Buttocks
Actual Study Start Date : June 1, 2017
Estimated Primary Completion Date : September 30, 2018
Estimated Study Completion Date : December 30, 2018

Arm Intervention/treatment
Experimental: Treatment Group
Treatment with the investigational device BTL EMSCULPT.
Device: Treatment with BTL EMSCULPT device.
The treatment administration phase will consist of four (4) treatments, delivered twice a week. The applicator will be applied over the buttock area. Visible contractions will be induced by the device.




Primary Outcome Measures :
  1. Patient's satisfaction with study treatment for non-invasive aesthetic improvement of buttocks. [ Time Frame: 18 months ]

    Subject's satisfaction with the therapy results evaluated through the Subject Satisfaction Questionnaire.

    The 5-point Likert scale Subject Satisfaction Questionnaire will be used for an analysis of the subject's opinion of the therapy results. Subjects will be evaluating agreement with three different statements (concerning satisfaction with therapy results and appearance of abdominal area after therapy) by choosing an answer on a scale between 1 (Strongly disagree) and 5 (Strongly agree). Minimally 80% of the treated subjects should report the agreement with all three statements given in the questionnaire (answers "Agree" and "Strongly agree") in order to claim subject's satisfaction with the therapy outcome.



Secondary Outcome Measures :
  1. Determining side effects and adverse events (AE) associated with the treatment of the gluteal area. [ Time Frame: 18 months ]
    The occurrence of adverse events throughout the whole study.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   22 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Voluntarily signed informed consent form
  • BMI ≤ 30 kg/m2
  • Women of child-bearing potential are required to use birth control measures during the whole duration of the study
  • Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation
  • Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting significant change in either direction during study participation

Exclusion Criteria:

  • Cardiac pacemakers
  • Electronic implants
  • Pulmonary insufficiency
  • Metal implants
  • Drug pumps
  • Haemorrhagic conditions
  • Anticoagulation therapy
  • Heart disorders
  • Malignant tumor
  • Fever
  • Pregnancy
  • Breastfeeding
  • Following recent surgical procedures when muscle contraction may disrupt the healing process
  • Application over menstruating uterus
  • Application over areas of the skin which lack normal sensation
  • Scars, open lesions and wounds at the treatment area
  • Unrepaired abdominal hernia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03575507


Locations
Layout table for location information
United States, Florida
Dr. Mariano Busso Aesthetic Dermatology
Miami, Florida, United States, 33133
Bulgaria
Aesthe Clinic
Sofia, Bulgaria, 1000
Sponsors and Collaborators
BTL Industries Ltd.

Layout table for additonal information
Responsible Party: BTL Industries Ltd.
ClinicalTrials.gov Identifier: NCT03575507     History of Changes
Other Study ID Numbers: BTL-Buttocks_002
First Posted: July 2, 2018    Key Record Dates
Last Update Posted: July 4, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Pediatric Postmarket Surveillance of a Device Product: No